AU1194997A - Plasmid vaccine against pseudorabies virus - Google Patents

Plasmid vaccine against pseudorabies virus

Info

Publication number
AU1194997A
AU1194997A AU11949/97A AU1194997A AU1194997A AU 1194997 A AU1194997 A AU 1194997A AU 11949/97 A AU11949/97 A AU 11949/97A AU 1194997 A AU1194997 A AU 1194997A AU 1194997 A AU1194997 A AU 1194997A
Authority
AU
Australia
Prior art keywords
vaccine against
pseudorabies virus
plasmid vaccine
against pseudorabies
plasmid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU11949/97A
Other versions
AU711915B2 (en
Inventor
Christophe Depierreux
Christine Swysen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimminaco AG
Original Assignee
Solvay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE9501059A external-priority patent/BE1009826A3/en
Priority claimed from BE9600533A external-priority patent/BE1010344A3/en
Application filed by Solvay SA filed Critical Solvay SA
Publication of AU1194997A publication Critical patent/AU1194997A/en
Assigned to DIMMINACO AG/SA/LTD. reassignment DIMMINACO AG/SA/LTD. Alteration of Name(s) of Applicant(s) under S113 Assignors: SOLVAY (SOCIETE ANONYME)
Assigned to DIMMINACO AG reassignment DIMMINACO AG Amend patent request/document other than specification (104) Assignors: DIMMINACO AG/SA/LTD.
Application granted granted Critical
Publication of AU711915B2 publication Critical patent/AU711915B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU11949/97A 1995-12-21 1996-12-06 Plasmid vaccine against pseudorabies virus Ceased AU711915B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
BE9501059 1995-12-21
BE9501059A BE1009826A3 (en) 1995-12-21 1995-12-21 Plasmid vaccine against pseudorabies virus
BE9600533A BE1010344A3 (en) 1996-06-12 1996-06-12 Plasmid vaccine against pseudorabies virus
BE9600533 1996-06-12
PCT/EP1996/005611 WO1997023502A1 (en) 1995-12-21 1996-12-06 Plasmid vaccine for pseudorabies virus

Publications (2)

Publication Number Publication Date
AU1194997A true AU1194997A (en) 1997-07-17
AU711915B2 AU711915B2 (en) 1999-10-21

Family

ID=25663019

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11949/97A Ceased AU711915B2 (en) 1995-12-21 1996-12-06 Plasmid vaccine against pseudorabies virus

Country Status (4)

Country Link
EP (1) EP0817799A1 (en)
AU (1) AU711915B2 (en)
CA (1) CA2216308A1 (en)
WO (1) WO1997023502A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110327461A (en) * 2019-07-17 2019-10-15 苏州世诺生物技术有限公司 A kind of preparation method and applications of porcine pseudorabies virus subunit vaccine

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751224B1 (en) * 1996-07-19 1998-11-20 Rhone Merieux POLYNUCLEOTIDE VACCINE FORMULA AGAINST BREATHING AND PIG REPRODUCTIVE CONDITIONS
AU2521899A (en) * 1998-01-26 1999-08-09 Sanofi Sante Nutrition Animale A virus vaccine of enhanced immunogenicity against aujeszky's disease
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
DE60113299T2 (en) * 2001-02-15 2006-06-08 Registrar, Indian Institute Of Science NEW VACCINE FORMULATION FROM DNA VACCINE INACTIVED VIRUS
DE102010016963A1 (en) 2010-05-17 2011-11-17 Krauss-Maffei Wegmann Gmbh & Co. Kg Weapon system, method for firing and detecting ammunition bodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0261940A3 (en) * 1986-09-23 1989-07-05 Applied Biotechnology, Inc. Pseudorabies vaccines and dna vectors for recombination with pox viruses
JP3573454B2 (en) * 1989-06-26 2004-10-06 パウダージェクト ヴァクシンズ，インコーポレイテッド Particle-mediated transformation of animal somatic cells
CA2089497A1 (en) * 1990-08-15 1992-02-16 Lendon Payne Self-assembling replication defective hybrid virus particles
JPH05246888A (en) * 1991-09-03 1993-09-24 Biseibutsu Kagaku Kenkyusho:Kk Component vaccine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110327461A (en) * 2019-07-17 2019-10-15 苏州世诺生物技术有限公司 A kind of preparation method and applications of porcine pseudorabies virus subunit vaccine
CN110327461B (en) * 2019-07-17 2022-06-24 苏州世诺生物技术有限公司 Preparation method and application of porcine pseudorabies virus subunit vaccine

Also Published As

Publication number Publication date
CA2216308A1 (en) 1997-07-03
AU711915B2 (en) 1999-10-21
EP0817799A1 (en) 1998-01-14
WO1997023502A1 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
AU4878096A (en) Hepatitis b vaccine
AU6304996A (en) Vaccines against hepatitis c
AU1308495A (en) Influenza vaccine
AU3434393A (en) Targeted virus
AU4781297A (en) Vaccines
HUP9601466A2 (en) Adjuvants for viral vaccines
HUP9601462A2 (en) Adjuvants for viral vaccines
AU3154395A (en) Contraceptive vaccine
GB9420146D0 (en) Papillomavirus vaccine
AU2769595A (en) Contraceptive vaccine
AU7465696A (en) Synthetic vaccine for protection against human immunodeficiency virus infection
AU1194997A (en) Plasmid vaccine against pseudorabies virus
AU6820796A (en) Antigenic preparations
AU1144197A (en) Salmonella vaccines
AU4450696A (en) Enhanced immunogenic vaccine
AU7628696A (en) Polyvalent anti-dengue vaccine
AU6715094A (en) Recombinant vaccine
AU1538895A (en) Anti-allergic vaccine
AU3552797A (en) Vaccine preparations
AU5959494A (en) Vaccines against sterols
AU6091796A (en) Isospora suis vaccine
AU5520796A (en) Peptide-based vaccine against papillomavirus infection
AU6736998A (en) Fiv vaccine
AU7336296A (en) Human hepatitis b virus dna
AU1991095A (en) Activating virus

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired